Beyond KRAS-driven cancers, autophagy dysregulation has been linked to a wide range of diseases including metabolic disorders, aging, and neurodegenerative diseases56, motivating investigation of 249C as a drug candidate for other treatment applications. The gene discussed is KRAS; the disease is metabolic disease.